Fellowship Director

• 

  Kelvin Moses, MD, PhD

  Associate Professor

  Department of Urology

  Joseph A. Smith Directorship in Urologic Oncology

  Fellowship Director

  Urologic Oncology Fellowship

  Division of Urologic Oncology

  Medical School: Baylor College of Medicine, Houston, TX
  Residency: Emory University School of Medicine, Atlanta, GA
  Fellowship: Memorial Sloan-Kettering Cancer Center, New York, NY
  Clinical Interests: Advanced Prostate Cancer, Advanced Kidney Cancer, Testis Cancer, Penile Cancer, Adrenal Cancer

  Dr. Moses is the Director of the Comprehensive Prostate Cancer clinic and Director of the Urologic Oncology Fellowship. He is the Chair of the NCCN Guidelines Panel on Early Detection of Prostate Cancer. His surgical practice focuses on advanced kidney cancer, including complex IVC thrombectomy and cytoreductive nephrectomy, and advanced testis cancer via retroperitoneal lymph node dissection.  He has research interests in health literacy and cancer outcomes, advanced prostate cancer clinical trials, optimal surgical resection for advanced Urologic cancers, and health disparities in Urologic cancers.

• 

  Daniel A. Barocas, MD, MPH, FACS

  Professor

  Department of Urology

  Executive Vice Chair

  Department of Urology

  Division of Urologic Oncology

  Medical School: Johns Hopkins University School of Medicine
  Residency: New York Presbyterian Hospital-Weill Cornell Medical Center
  Fellowship: Vanderbilt University Medical Center
  Clinical Interests: Genitourinary Cancer, Prostate Cancer, Kidney Cancer, Bladder Cancer, Laparoscopy and Robotics

  Dr. Barocas is an accomplished researcher, focusing on quality of life, quality of care, healthcare disparities and comparative effectiveness. He is the principal investigator of a multi-center study on the effectiveness and side effects of different treatments for prostate cancer.

• 

  Sam S. Chang, MD, MBA

  Professor

  Department of Urology

  Patricia and Rodes Hart Professor of Urologic Surgery

  Chief Surgical Officer

  Vanderbilt Ingram Cancer Center

  Chief

  Division of Urologic Oncology

  Medical School: Vanderbilt University School of Medicine
  Residency: Vanderbilt University Medical Center
  Fellowship: Memorial Sloan-Kettering Cancer Center
  Clinical Interests: Prostate cancer, Prostatectomy, Bladder cancer, Kidney cancer, Urologic cancer

  Dr. Chang, the Chief Surgical Officer at the Vanderbilt Ingram Cancer Center and the Urologic Oncology Division Chief, formerly chaired the American Joint Committee on GU Cancer Staging and the AUA/ASCO Guidelines on Bladder Cancer and was a member of the AUA Guidelines on Renal Cancer and the SUO Guidelines on Advanced Prostate Cancer.  He is the past Chair of the American Board of Urology Examination Committee responsible for U.S. board certification and has been selected to serve as a Trustee of the American Board of Urology.   His research in urologic oncology and clinical efforts have been recognized with national awards include the Distinguished Service Award of the SUO and the Gold Cystoscope Award and Hugh Hampton Young Award from the AUA.

• 

  Daniel D. Joyce, MD, MS

  Assistant Professor

  Department of Urology

  Division of Urologic Oncology

  Medical School: Mayo Medical School
  Residency: Vanderbilt University Medical Center
  Fellowship: Mayo Clinic, Rochester MN
  Clinical Interests: Kidney Cancer, Testis Cancer, Bladder Cancer, Prostate cancer, Genitourinary cancer

  Dr. Joyce completed a Society of Urologic Oncology fellowship and master’s degree with a concentration in healthcare delivery at the Mayo Clinic in Rochester, MN where he also attended medical school. He received a Bachelor of Fine Arts, graduating with honors, from New York University and completed his urology residency at Vanderbilt University Medical Center in Nashville, TN. He is a member of the AOA honor medical society, currently serves as an editor for The Journal of Urology, and formerly served as the Southeastern Section representative for the American Urological Association residents and fellows committee. Dr. Joyce’s clinical practice includes a broad range of both robotic and open approaches to surgical management of genitourinary malignancies. His research interests include improving value in healthcare and mitigating financial toxicity of cancer treatments through use of cost modeling and patient-reported outcome measures, as well as harnessing new technologies to improve physician-patient interactions.

• 

  Amy N. Luckenbaugh, MD, FACS

  Assistant Professor

  Department of Urology

  Division of Urologic Oncology

  Medical Degree: State University of New York at Buffalo
  Residency: University of Michigan
  Fellowship: Vanderbilt University Medical Center
  Clinical Interests: Bladder Cancer, Kidney Cancer, Prostate Cancer, Testis Cancer, Urologic Cancer

  Dr. Luckenbaugh is a high-volume surgeon whose clinical focus centers around the comprehensive care of patients with urologic malignancies. She currently serves as the chair of Women in Urologic Oncology, and the secretary for the Society of Women in Urology, and through her research aims to mitigate variation in healthcare delivery.

• 

  David F. Penson, MD, MPH, MMHC

  Professor and Chair

  Department of Urology

  Hamilton and Howd Chair in Urologic Oncology

  Division of Urologic Oncology

  Medical School: Boston University School of Medicine
  Residency: University of California, Los Angeles
  Fellowship: Robert Wood Johnson Clinical Scholars Program, Yale University
  Clinical Interests: Prostate cancer, Bladder cancer, Prostatectomy, Elevated PSA

  Dr Penson serves as Chair of the Department and oversees all Departmental activities. He is also a well-known health services researcher, a urologic oncologist who focuses primarily on clinical prostate cancer care and, most importantly, the father of three great kids (all of whom are die-hard Boston Red Sox fans, like their dad).

• 

  Joseph A. Smith, Jr, MD

  Professor

  Department of Urology

  William L. Bray Professor

  Division of Urologic Oncology

  Medical School: University of Tennessee School of Medicine
  Residency: University of Texas Southwestern Medical School/University of Utah
  Fellowship: Memorial Sloan-Kettering Cancer Center
  Clinical Interests: Bladder cancer, Prostate cancer, Prostatectomy, Urologic Cancer, Genitourinary Cancer

  Dr Smith's career has been focused on innovative surgical treatment for urologic cancer.  He has transitioned from his surgical practice at Vanderbilt and now is Director of Global Surgery for the Department.  He oversees and participates in humanitarian surgical efforts throughout the world and coordinates the participation of residents, fellows, and other faculty at Vanderbilt.

• 

  Kristen R. Scarpato, MD, MPH

  Associate Professor

  Department of Urology

  Residency Program Director

  Department of Urology

  Vice Chair of Education

  Department of Urology

  Division of Urologic Oncology

  Medical Degree: Tufts University School of Medicine
  Residency: University of Connecticut Health Center
  Fellowship: Vanderbilt University Medical Center
  Clinical Interests: Bladder Cancer, Genitourinary Cancer, Prostate Cancer, Prostatectomy, Ultrasound Fusion Biopsy/Artemis
   

  Dr. Scarpato, MD, MPH, is an Associate Professor and the Director of the Urology Residency Program and Vice Chair of Education. She has interests in resident and medical student education, surgical simulation, and mentorship. She remains committed to advancing the field of urology through education and maintains a strong interest in both patient and resident education. She enjoys collaborating on educational endeavors with numerous local and national organizations. Dr. Scarpato’s clinical practice focuses on the diagnosis and management of bladder and prostate cancer. She has a particular interest in focal therapy and salvage prostate ablation, as well as advanced prostate cancer.

• 

  Cary (CJ) Stimson, MD, JD

  Assistant Professor

  Department of Urology

  Senior Vice President of Value Transformation

  Office of Population Health

  Chief Medical Officer

  VUMC and Vanderbilt University Employee Health Plan

  Division of Urologic Oncology

  Medical School: Vanderbilt University School of Medicine, Nashville, TN
  Residency: Vanderbilt University Medical Center, Nashville, TN
  Fellowship: Johns Hopkins Hospital, Baltimore, MD

• 

  Ruchika Talwar, MD, MMHC

  Assistant Professor

  Department of Urology

  Medical Director

  Episodes of Care, Population Health

  Division of Urologic Oncology

  Medical School: Rutgers New Jersey Medical School, Newark, NJ
  Residency: University of Pennsylvania, Philadelphia, PA
  Fellowship: Vanderbilt University Medical Center

  Dr. Ruchika Talwar is a urologic oncologist at Vanderbilt University Medical Center and Medical Director in the Episodes of Care Office, where she leads and operationalizes VUMC’s specialty value-based care programs, including Medicare models and the innovative MyHealth Bundles program. She is a residency graduate from the University of Pennsylvania in Philadelphia, PA, where she was affiliated with the Leonard Davis Institute of Health Economics at the Wharton School. She completed a Society of Urologic Oncology (SUO) fellowship and Masters of Management in Healthcare at Vanderbilt University. Dr. Talwar has served in several national leadership roles within organized medicine, including Chair of the American Urological Association's residents and fellows committee, the Health Policy, Young Urologic Oncologists, and Women in Urologic Oncology Committees of the SUO, and is currently the Fundraising Chair for the AUAPAC. She held the H. Logan Holtgrewe Legislative Fellowship in 2022, when she spent time working on Capitol Hill in the office of Congressman Darren Soto (FL-09). Dr. Talwar’s clinical practice includes both robotic and open approaches to urologic cancer surgery, with a focus on patient-centered care. Her academic work in health policy, value transformation, drug pricing, and costs of care has been published in several JAMA journals and the Journal of Clinical Oncology. She makes several trips a year to Washington, DC, meeting with Congressional representatives as a passionate advocate for improving the quality of care provided to patients in the US. 

• 

  Jeffrey Tosoian, MD, MPH

  Assistant Professor

  Department of Urology

  Director of Translational Cancer Research

  Division of Urologic Oncology

  Medical School: Johns Hopkins University School of Medicine
  Residency: Johns Hopkins Medical Institutions
  Fellowship: University of Michigan, Urologic Oncology and Translational Cancer Research
  Clinical Interests: Elevated PSA, Prostate Cancer, Kidney Cancer, Bladder Cancer, Testis Cancer

  Dr. Tosoian specializes in the early diagnosis and management of urologic cancers. In addition to his role as a clinician and surgeon, he is a recognized leader in clinical and translational prostate cancer research. His early research demonstrated the safety of monitoring lower-risk prostate cancers on active surveillance, allowing appropriately selected patients to delay or avoid treatment altogether. His ongoing research has led to the development of new, non-invasive tools to guide cancer diagnosis and management. Dr. Tosoian leads the Prostate Cancer Risk Clinic, a clinical program for informed early screening in patients with a strong family history or known genetic mutation associated with prostate cancer.